Brandi Roberts - 02 Jun 2025 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: MNMD
Reported as of: 02 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2025, 17:40:03 UTC
Prior SEC filing: 02 Dec 2024
Next SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Sullivan, Attorney-in-Fact for Brandi Roberts

Key filing fact

Brandi Roberts filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 02 Jun 2025.

Key facts

This page summarizes Brandi Roberts's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jun 2025, 17:40.

Change

Previous filing in this sequence was filed on 02 Dec 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001516354 Primary reporting owner

Roberts Brandi

Relationship: Chief Financial Officer
Address: C/O MIND MEDICINE (MINDMED) INC., ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK
Signature: /s/ Mark Sullivan, Attorney-in-Fact for Brandi Roberts
Signature date: 02 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 02 Jun 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 500,000
Exercise price: $7.26
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying the option shall vest and become exercisable over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.